Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 23 (5), 473-9

Targeting the Immune System to Treat Hypertension: Where Are We?

Affiliations
Review

Targeting the Immune System to Treat Hypertension: Where Are We?

Jennifer L Gooch et al. Curr Opin Nephrol Hypertens.

Abstract

Purpose of review: Research over the past decade has significantly deepened our understanding of mechanisms that drive the development of hypertension. In particular, a novel paradigm of inflammation as a common mediator of cardiovascular and kidney disease has emerged. This review will summarize the role of the immune system in cardiovascular disease, explore some of the most promising new therapeutic directions and consider their potential as new treatments for hypertension.

Recent findings: Recent data continue to demonstrate that targeting the immune system can prevent hypertension in a variety of experimental models. Tempering the enthusiasm for a long-awaited new approach to treating hypertension is decades of clinical data, showing that classic immunosuppression regimens are associated with significant side-effects - including cardiovascular disease - that effectively preclude their use in the setting of chronic hypertension. New, more specific therapies are being developed that target cytokines including IL-17, IL-6 and TNFα.

Summary: Preclinical data convincingly demonstrate a key role for the immune system and specific cytokine mediators. Several biotherapeutics targeting these pathways are on the market and more are in development. Side-effects, however, continue to resemble those of classic immunosuppressants, highlighting the challenge of translating these research advances into new therapies for hypertension.

Video abstract: http://links.lww.com/CONH/A9.

Similar articles

  • The Immune System in Hypertension
    DG Harrison. Trans Am Clin Climatol Assoc 125, 130-38; discussion 138-40. PMID 25125726. - Review
    Hypertension is generally attributed to perturbations of the vasculature, the kidney, and the central nervous system. During the past several years, it has become apparen …
  • Relevance of Immune-Sympathetic Nervous System Interplay for the Development of Hypertension
    PJ Winklewski et al. Adv Exp Med Biol 884, 37-43. PMID 26453069. - Review
    Historically, the sympathetic nervous system (SNS) has been mostly associated with the 'fight or flight' response and the regulation of cardiovascular function. However, …
  • Novel Pathophysiological Mechanisms in Hypertension
    R Samson et al. Adv Exp Med Biol 956, 21-35. PMID 27981434. - Review
    Hypertension is the most common disease affecting humans and imparts a significant cardiovascular and renal risk to patients. Extensive research over the past few decades …
  • The Immune System in Hypertension
    DW Trott et al. Adv Physiol Educ 38 (1), 20-4. PMID 24585465. - Review
    While hypertension has predominantly been attributed to perturbations of the vasculature, kidney, and central nervous system, research for almost 50 yr has shown that the …
  • Cytokine Networking of Innate Immunity Cells: A Potential Target of Therapy
    I Striz et al. Clin Sci (Lond) 126 (9), 593-612. PMID 24450743. - Review
    Innate immune cells, particularly macrophages and epithelial cells, play a key role in multiple layers of immune responses. Alarmins and pro-inflammatory cytokines from t …
See all similar articles

Cited by 5 PubMed Central articles

Publication types

MeSH terms

Feedback